Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph phase_2
1
20%
Ph phase_4
2
40%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(1)
Other(3)

Detailed Status

unknown3
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

unknown360%
terminated120%
completed120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT06132165
terminatedphase_4

An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst

NCT02154789
unknownphase_4

Comparative Study of Polidocanol and Absolute Alcohol for Percutaneous us Guided Treatment of Benign Thyroid Cyst

NCT05798936
unknownnot_applicable

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

NCT05633277
unknownphase_2

TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies

NCT01185951

Clinical Trials (5)

Showing 5 of 5 trials
NCT06132165Phase 1

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Completed
NCT02154789Phase 4

An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst

Terminated
NCT05798936Phase 4

Comparative Study of Polidocanol and Absolute Alcohol for Percutaneous us Guided Treatment of Benign Thyroid Cyst

Unknown
NCT05633277Not Applicable

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

Unknown
NCT01185951Phase 2

TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5